MedTrace Logo

Evaluation of the Electronic Cigarette Withdrawal Syndrome

NCT06066996 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-07-14

No results posted yet for this study

Summary

The goal of this project is to rigorously evaluate the nature of e-cigarette withdrawal in exclusive e-cigarette users during a monitored abstinence period and the role of nicotine in the expression of this withdrawal syndrome.

Conditions

  • E-cigarette Use
  • Withdrawal

Interventions

DRUG

Transdermal Nicotine Patch

Blinded Nicotine Patch

DRUG

Placebo Nicotine Patch

Blinded Patch with No Nicotine

Sponsors & Collaborators

Principal Investigators

  • Justin Strickland, Ph.D. · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-28
Primary Completion
2028-06-30
Completion
2028-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06066996 on ClinicalTrials.gov